Syndax Pharmaceuticals (SNDX) Accumulated Depreciation & Amortization (2016 - 2025)
Syndax Pharmaceuticals (SNDX) has 10 years of Accumulated Depreciation & Amortization data on record, last reported at $419000.0 in Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 1.95% year-over-year to $419000.0; the TTM value through Dec 2024 reached $419000.0, up 1.95%, while the annual FY2024 figure was $419000.0, 1.95% up from the prior year.
- Accumulated Depreciation & Amortization reached $419000.0 in Q4 2024 per SNDX's latest filing, up from $411000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $443000.0 in Q4 2021 and bottomed at $399000.0 in Q4 2020.
- Average Accumulated Depreciation & Amortization over 5 years is $414200.0, with a median of $411000.0 recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: rose 28.71% in 2020, then decreased 9.93% in 2022.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $399000.0 in 2020, then increased by 11.03% to $443000.0 in 2021, then fell by 9.93% to $399000.0 in 2022, then increased by 3.01% to $411000.0 in 2023, then grew by 1.95% to $419000.0 in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $419000.0 in Q4 2024, $411000.0 in Q4 2023, and $399000.0 in Q4 2022.